Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28
Benzinga Newsdesk 2 months ago
NewsDowngradesAnalyst RatingsPrice Target
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.